Skip to main content

Table 5 Association between imaging findings and adverse clinical outcomes of COVID-19

From: Can initial chest CT scan predict status and clinical outcomes of COVID-19 infection? A retrospective cohort study

Outcomes Imaging findings Adjusteda OR (95% CI) P value
ICU admission Ground glass 0.42 (0.09–1.99) 0.274
Consolidation 2.23 (0.62–7.95) 0.218
Bilateral lung involvement 3.66 (0.38–35.23) 0.262
Peribronchovascular distribution 2.93 (1.92–4.47) < 0.001
Involved zones 2.10 (1.55–2.86) < 0.001
CSS (continuous) 1.14 (1.10–1.19) < 0.001
CSS ≥ 19 3.21 (2.15–4.81) < 0.001
Mortality Consolidation 1.72 (0.63–4.65) 0.288
Peribronchovascular distribution 2.30 (1.50–3.53) < 0.001
Involved zones 1.35 (1.05–1.74) 0.020
CSS (continuous) 1.08 (1.04–1.12) < 0.001
CSS ≥ 19 1.84 (1.21–2.81) 0.004
Disease severityb
 Severe Ground glass 0.51 (0.13–2.02) 0.337
Consolidation 4.94 (1.22–20.02) 0.025
Peribronchovascular distribution 2.06 (1.26–3.35) 0.004
Involved zones 1.68 (1.29–2.18) 0.001
CSS (continuous) 1.10 (1.06–1.14) < 0.001
CSS ≥ 19 3.18 (2.05–4.93) < 0.001
 Critical Ground glass 0.28 (0.04–1.89) 0.195
Consolidation 3.06 (0.74–12.68) 0.123
Peribronchovascular distribution 4.62 (2.64–8.10) < 0.001
Involved zones 3.21 (2.25–4.58) < 0.001
CSS (continuous) 1.23 (1.16–1.29) < 0.001
CSS ≥ 19 6.25 (3.74–10.41) < 0.001
  1. OR odds ratio, CI confidence interval
  2. aAdjusted for patients’ comorbidities (cardiovascular diseases, asthma/chronic obstructive pulmonary disease, and diabetes) and imaging findings
  3. bBased on the World Health Organization criteria. “Moderate” disease was reference